43 results
Page 2 of 3
20-F/A
EX-4.39
9lbdg
23 Mar 15
Annual report (foreign) (amended)
12:00am
424B2
hf9wgx8
13 Jun 14
Prospectus for primary offering
12:00am
6-K
EX-1.1
sqyvewv4f
30 May 14
Current report (foreign)
12:00am
F-3
ec87vjh
30 May 14
Shelf registration (foreign)
12:00am
6-K
EX-1.1
4416n
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B3
wg27hgn
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-10.1
julafl rp
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B3
hozqi0 sm90
15 Oct 12
Prospectus supplement
12:00am
F-1
pm0nuwmn
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99
huts3my3iwouc hotnt
27 Sep 12
Current report (foreign)
12:00am
S-8
EX-3.1
3p9td77a
19 Sep 12
Registration of securities for employees
12:00am
424B3
uac6 k8ly
2 Aug 12
Prospectus supplement
12:00am
POS AM
elssk8
25 Jul 12
Prospectus update (post-effective amendment)
12:00am
F-3/A
56btfr jioca4j7wiv
23 Jul 12
Shelf registration (foreign) (amended)
12:00am
424B3
53fpa7u ffz56
28 Mar 12
Prospectus supplement
12:00am
6-K
EX-1
q7yzgczahdl9osc
13 Oct 11
Current report (foreign)
12:00am
20FR12B
EX-4.19
jb7100565vefsb30sbz
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.4
q4ne0vbv0s i1msih5yg
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.17
wvk75t0ki i6mqdz5
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.24
6jrqlkmu0zmnb1hza
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am